Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). (Q42693733)
Jump to navigation
Jump to search
scientific article published on 18 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). |
scientific article published on 18 November 2014 |
Statements
1 reference
Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). (English)
1 reference
T Sugimoto
1 reference
T Matsumoto
1 reference
T Hosoi
1 reference
T Miki
1 reference
I Gorai
1 reference
H Yoshikawa
1 reference
Y Tanaka
1 reference
S Tanaka
1 reference
M Fukunaga
1 reference
T Sone
1 reference
T Nakano
1 reference
M Ito
1 reference
S Matsui
1 reference
T Yoneda
1 reference
H Takami
1 reference
K Watanabe
1 reference
T Osakabe
1 reference
N Okubo
1 reference
M Shiraki
1 reference
T Nakamura
1 reference
18 November 2014
1 reference
1 reference
26
1 reference
2
1 reference
765-774
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference